Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apex Healthcare | Kuala Lumpur | Salute | Prodotti farmaceutici | 1,76 Mrd MYR | 21,1x | -0,27 | 2,43 MYR | -1,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 16,7% Rialzo | Fai l’upgrade a Pro+ | |
Duopharma Biotech | Kuala Lumpur | Salute | Prodotti farmaceutici | 1,21 Mrd MYR | 21,5x | -2,36 | 1,25 MYR | -0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 14,7% Rialzo | Fai l’upgrade a Pro+ | |
Amway | Kuala Lumpur | Salute | Prodotti farmaceutici | 1,12 Mrd MYR | 9,1x | 0,61 | 6,80 MYR | 0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 4,6% Rialzo | Fai l’upgrade a Pro+ | |
Kotra Industries | Kuala Lumpur | Salute | Prodotti farmaceutici | 654,07 Mln MYR | 16,1x | -0,51 | 4,41 MYR | -1,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 4,7% Rialzo | Fai l’upgrade a Pro+ | |
Pharmaniaga Bhd | Kuala Lumpur | Salute | Prodotti farmaceutici | 518,84 Mln MYR | 5,5x | 0,05 | 0,35 MYR | -1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 8,3% Rialzo | Fai l’upgrade a Pro+ | |
YSP Southeast Asia | Kuala Lumpur | Salute | Prodotti farmaceutici | 326,24 Mln MYR | 11,4x | -0,64 | 2,30 MYR | -1,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Rhone Ma | Kuala Lumpur | Salute | Prodotti farmaceutici | 148,22 Mln MYR | 12,1x | 1,89 | 0,67 MYR | -1,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 3,7% Rialzo | Fai l’upgrade a Pro+ | |
Bioalpha | Kuala Lumpur | Salute | Prodotti farmaceutici | 91,42 Mln MYR | -2,1x | -0,12 | 0,06 MYR | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |